These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10965230)
1. Blood interleukin-6 and tumor necrosis factor-alpha elevation after intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors: peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism. Chen G; McCuskey RS; Reichlin S Neuroimmunomodulation; 2000; 8(2):59-69. PubMed ID: 10965230 [TBL] [Abstract][Full Text] [Related]
2. Clearance of [125I]-tumor necrosis factor-alpha from the brain into the blood after intracerebroventricular injection in rats. Chen G; Reichlin S Neuroimmunomodulation; 1998; 5(5):261-9. PubMed ID: 9730694 [TBL] [Abstract][Full Text] [Related]
3. Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. Campisi J; Hansen MK; O'Connor KA; Biedenkapp JC; Watkins LR; Maier SF; Fleshner M J Appl Physiol (1985); 2003 Nov; 95(5):1873-82. PubMed ID: 12871965 [TBL] [Abstract][Full Text] [Related]
4. Clearance of 125I-labeled interleukin-6 from brain into blood following intracerebroventricular injection in rats. Chen G; Castro WL; Chow HH; Reichlin S Endocrinology; 1997 Nov; 138(11):4830-6. PubMed ID: 9348212 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms by which blood levels of interleukin-6 (IL-6) are elevated after intracerebroventricular injection of IL-1beta in the rat: neural versus humoral control. Chen G; Reichlin S Endocrinology; 1999 Dec; 140(12):5549-55. PubMed ID: 10579318 [TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular passive immunization. I. The effect of intracerebroventricular administration of an antiserum to tumor necrosis factor-alpha on the plasma adrenocorticotropin response to lipopolysaccharide in rats. Turnbull AV; Rivier CL Endocrinology; 1998 Jan; 139(1):119-27. PubMed ID: 9421406 [TBL] [Abstract][Full Text] [Related]
7. Aged mice exhibit greater mortality concomitant to increased brain and plasma TNF-alpha levels following intracerebroventricular injection of lipopolysaccharide. Kalehua AN; Taub DD; Baskar PV; Hengemihle J; Muñoz J; Trambadia M; Speer DL; De Simoni MG; Ingram DK Gerontology; 2000; 46(3):115-28. PubMed ID: 10754368 [TBL] [Abstract][Full Text] [Related]
8. Different roles of brain interleukin 1 in the adrenocorticotropin response to central versus peripheral administration of lipopolysaccharide in the rat. Habu S; Watanobe H; Yasujima M; Suda T Cytokine; 1998 May; 10(5):390-4. PubMed ID: 9619378 [TBL] [Abstract][Full Text] [Related]
10. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Lang CH; Silvis C; Deshpande N; Nystrom G; Frost RA Shock; 2003 Jun; 19(6):538-46. PubMed ID: 12785009 [TBL] [Abstract][Full Text] [Related]
11. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Hansen MK; Nguyen KT; Goehler LE; Gaykema RP; Fleshner M; Maier SF; Watkins LR Auton Neurosci; 2000 Dec; 85(1-3):119-26. PubMed ID: 11189018 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Luheshi G; Miller AJ; Brouwer S; Dascombe MJ; Rothwell NJ; Hopkins SJ Am J Physiol; 1996 Jan; 270(1 Pt 1):E91-5. PubMed ID: 8772479 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist. Xiao E; Xia-Zhang L; Ferin M Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1 beta in rats. Romero LI; Kakucska I; Lechan RM; Reichlin S Am J Physiol; 1996 Mar; 270(3 Pt 2):R518-24. PubMed ID: 8780215 [TBL] [Abstract][Full Text] [Related]
15. Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide. Gottschall PE; Komaki G; Arimura A Neuroendocrinology; 1992 Dec; 56(6):935-8. PubMed ID: 1369606 [TBL] [Abstract][Full Text] [Related]
16. Role of central IL-1 in regulating peripheral IGF-I during endotoxemia and sepsis. Lang CH; Fan J; Wojnar MM; Vary TC; Cooney R Am J Physiol; 1998 Apr; 274(4):R956-62. PubMed ID: 9575956 [TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of fever after intravenous administration of endotoxin. Caldwell FT; Graves DB; Wallace BH J Trauma; 1998 Feb; 44(2):304-12. PubMed ID: 9498502 [TBL] [Abstract][Full Text] [Related]
18. Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Miller AJ; Luheshi GN; Rothwell NJ; Hopkins SJ Am J Physiol; 1997 Mar; 272(3 Pt 2):R857-61. PubMed ID: 9087647 [TBL] [Abstract][Full Text] [Related]
19. Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Janský L; Vybíral S; Pospísilová D; Roth J; Dornand J; Zeisberger E; Kamínková J Neuroendocrinology; 1995 Jul; 62(1):55-61. PubMed ID: 7566439 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and tumor necrosis factor in cerebrospinal fluid: changes during pyrogen fever. Coceani F; Lees J; Mancilla J; Belizario J; Dinarello CA Brain Res; 1993 May; 612(1-2):165-71. PubMed ID: 8330197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]